Intent to Grant an Exclusive License of U.S. Government-Owned Inventions, 34968 [2011-14802]
Download as PDF
34968
Federal Register / Vol. 76, No. 115 / Wednesday, June 15, 2011 / Notices
96814–4700; phone (808) 944–2200; fax
(808) 973–2941.
Written comments or requests for a
public hearing on this request should be
submitted to the Chief, Permits,
Conservation and Education Division, at
the address listed above. Comments may
also be submitted by facsimile to (301)
713–0376, or by e-mail to
NMFS.Pr1Comments@noaa.gov. Please
include the File No. in the subject line
of the e-mail comment.
Those individuals requesting a
hearing should set forth the specific
reasons why a hearing on this particular
modification request would be
appropriate.
FOR FURTHER INFORMATION CONTACT:
Amy Hapeman or Kristy Beard, (301)
713–2289.
The
subject modification to Permit No.
10027, issued on July 30, 2008 (73 FR
44224), is requested under the authority
of the Endangered Species Act of 1973,
as amended (16 U.S.C. 1531 et seq.) and
the regulations governing the taking,
importing, and exporting of endangered
and threatened species (50 CFR 222–
226).
The permit currently authorizes the
permit holder to study the population
biology and connectivity of green
(Chelonia mydas) and hawksbill
(Eretmochelys imbricata) sea turtles
focusing on distribution and abundance,
ecology, health, and threats to sea
turtles at the Palmyra Atoll in the
Pacific Ocean. The permit holder
requests a modification to their existing
permit to increase the number of green
sea turtles taken annually from 100 to
250 turtles per year. Of the total 250
green sea turtles, researchers request to
increase the number tagged with sonic
transmitters from 30 to 40 turtles
annually. The modification is needed to
accommodate higher than anticipated
capture rates and an increase in capture
efforts. These data will help determine
if temporal, stage-specific, or sexspecific movement patterns exist for the
population of sea turtles at Palmyra. The
modified permit would expire July 31,
2013.
jlentini on DSK4TPTVN1PROD with NOTICES
SUPPLEMENTARY INFORMATION:
Dated: June 10, 2011.
Tammy C. Adams,
Acting Chief, Permits, Conservation and
Education Division, Office of Protected
Resources, National Marine Fisheries Service.
[FR Doc. 2011–14857 Filed 6–14–11; 8:45 am]
BILLING CODE 3510–22–P
VerDate Mar<15>2010
16:42 Jun 14, 2011
Jkt 223001
Department of the Army
Intent to Grant an Exclusive License of
U.S. Government-Owned Inventions
April 20, 2011. The United States
Government, as represented by the
Secretary of the Army, has rights to this
invention.
ADDRESSES:
DEPARTMENT OF DEFENSE
Department of the Army, DoD.
Notice.
AGENCY:
ACTION:
In accordance with 35 U.S.C.
209(e), and 37 CFR 404.7(a)(1)(i) and 37
CFR 404.7(b)(1)(i), announcement is
made of the intent to grant an exclusive,
revocable license to the invention
claimed in the PCT/US2009/060091
(Publication Number WO 2010/042780),
entitled ‘‘Methods and Compositions for
Treating Status Epilepticus and Seizures
Causing Status Epilepticus’’, to
Biomedisyn Corporation with its
principal place of business at 12 Indian
Trail Road, Woodbridge, Connecticut
06525.
ADDRESSES: Commander, U.S. Army
Medical Research and Materiel
Command, ATTN: Command Judge
Advocate, MCMR–JA, 504 Scott Street,
Fort Detrick, MD 21702–5012.
FOR FURTHER INFORMATION CONTACT: For
licensing issues, Dr. Paul Mele, Office of
Research & Technology Applications,
(301) 619–6664. For patent issues, Ms.
Elizabeth Arwine, Patent Attorney, (301)
619–7808; both at telefax (301) 619–
5034.
SUPPLEMENTARY INFORMATION: Anyone
wishing to object to grant of this license
can file written objections along with
supporting evidence, if any, within 15
days from the date of this publication.
Written objections are to be filed with
the Command Judge Advocate (see
ADDRESSES).
SUMMARY:
Commander, U.S. Army
Medical Research and Materiel
Command, ATTN: Command Judge
Advocate, MCMR–JA, 504 Scott Street,
Fort Detrick, Frederick, MD 21702–
5012.
For
patent issues, Ms. Elizabeth Arwine,
Patent Attorney, (301) 619–7808. For
licensing issues, Dr. Paul Mele, Office of
Research and Technology Applications
(ORTA), (301) 619–6664, both at telefax
(301) 619–5034.
FOR FURTHER INFORMATION CONTACT:
The
invention relates to a dynamic
exoskeletal orthosis applied to the leg
below the knee, designed to compensate
for weakness, pain, and/or decreased
range of motion at the ankle.
SUPPLEMENTARY INFORMATION:
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2011–14803 Filed 6–14–11; 8:45 am]
BILLING CODE 3710–08–P
DEPARTMENT OF DEFENSE
Department of the Army
Notice of Availability for Exclusive,
Non-Exclusive, or Partially-Exclusive
Licensing of an Invention Concerning
the Methods and Compositions for
Treating Status Epilepticus and
Seizures Causing Status Epilepticus
AGENCY:
Department of the Army, DoD.
Notice.
Brenda S. Bowen,
Army Federal Register Liaison Officer.
ACTION:
[FR Doc. 2011–14802 Filed 6–14–11; 8:45 am]
SUMMARY:
BILLING CODE 3710–08–P
DEPARTMENT OF DEFENSE
Department of the Army
Notice of Availability for Exclusive,
Non-Exclusive, or Partially; Exclusive
Licensing of an Invention Concerning
the Intrepid Dynamic Exoskeletal
Orthosis
Department of the Army, DoD.
Notice.
AGENCY:
ACTION:
Announcement is made of the
availability for licensing of the
invention set forth in U.S. Provisional
Patent Application Serial No.
61/518,801, entitled ‘‘Intrepid Dynamic
Exoskeletal Orthosis (IDEO),’’ filed on
SUMMARY:
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
Announcement is made of the
availability for licensing of the
invention set forth in the PCT/US2009/
060091, entitled ‘‘Methods and
Compositions for Treating Status
Epilepticus and Seizures Causing Status
Epilepticus’’ filed on October 9, 2009.
The United States Government, as
represented by the Secretary of the
Army, has rights to this invention. U.S.
and selected foreign rights are available.
Commander, U.S. Army
Medical Research and Materiel
Command, ATTN: Command Judge
Advocate, MCMR–JA, 504 Scott Street,
Fort Detrick, MD 21702–5012.
ADDRESSES:
For
licensing issues, Dr. Paul Mele, Office of
Research & Technology Applications,
(301) 619–6664. For patent issues, Ms.
Elizabeth Arwine, Patent Attorney, (301)
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\15JNN1.SGM
15JNN1
Agencies
[Federal Register Volume 76, Number 115 (Wednesday, June 15, 2011)]
[Notices]
[Page 34968]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-14802]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF DEFENSE
Department of the Army
Intent to Grant an Exclusive License of U.S. Government-Owned
Inventions
AGENCY: Department of the Army, DoD.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In accordance with 35 U.S.C. 209(e), and 37 CFR 404.7(a)(1)(i)
and 37 CFR 404.7(b)(1)(i), announcement is made of the intent to grant
an exclusive, revocable license to the invention claimed in the PCT/
US2009/060091 (Publication Number WO 2010/042780), entitled ``Methods
and Compositions for Treating Status Epilepticus and Seizures Causing
Status Epilepticus'', to Biomedisyn Corporation with its principal
place of business at 12 Indian Trail Road, Woodbridge, Connecticut
06525.
ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command,
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick,
MD 21702-5012.
FOR FURTHER INFORMATION CONTACT: For licensing issues, Dr. Paul Mele,
Office of Research & Technology Applications, (301) 619-6664. For
patent issues, Ms. Elizabeth Arwine, Patent Attorney, (301) 619-7808;
both at telefax (301) 619-5034.
SUPPLEMENTARY INFORMATION: Anyone wishing to object to grant of this
license can file written objections along with supporting evidence, if
any, within 15 days from the date of this publication. Written
objections are to be filed with the Command Judge Advocate (see
ADDRESSES).
Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2011-14802 Filed 6-14-11; 8:45 am]
BILLING CODE 3710-08-P